Qualitative Analysis of Community Support to Methadone Access in Kenya

References

• Abdool, R. (2016). Policy change towards implementing harm reduction in Sub-Saharan Africa. International Journal of Drug Policy, 30, 140–142. https://doi.org/10.1016/j.drugpo.2016.03.001
   PubMed Web of Science ®Google Scholar
• Ayon, S., Ndimbii, J., Jeneby, F., Abdulrahman, T., Mlewa, O., Wang, B., Ragi, A., & Mburu, G. (2018). Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: Role of community-based outreach and drop-in centers. AIDS Care Journal, 30(4), 480–487. https://doi.org/10.1080/09540121.2017.1394965
   PubMed Web of Science ®Google Scholar
• Blankenship, K. M., Friedman, S. R., Dworkin, S., & Mantell, J. E. (2006). Structural interventions: Concepts. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 83(1), 59–72. https://doi.org/10.1007/s11524-005-9007-4
   PubMed Web of Science ®Google Scholar
• Blackenship, K., Reinhard, E., Sherman, S., & Nabila, E.-B. (2015). Structural interventions for HIV prevention among women who use drugs: A global perspective. Journal of Acquired Immune Deficiency Syndromes,  69 Suppl 2, S140–S145.
   Web of Science ®Google Scholar
• Broadhead, R. S., Heckathom, D. D., Altice, F. L., Van Hulst, Y., Carbone, M., & Friedland, G. H. (2002). Increasing drug users’ adherence to HIV treatment: Results of a peer-driven intervention feasibility study. Social Science & Medicine, 55(22), 235–246.
   PubMedGoogle Scholar
• Bourgois, P. (2000). Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry, 24(2), 165–195. https://doi.org/10.1023/A:1005574918294
   PubMed Web of Science ®Google Scholar
• Bruce, D. (2010). Methadone as HIV Prevention: High Volume Methadone Sites to Decrease HIV Incidence Rates in Resource Limited Settings. International Journal of Drug Policy, 122–124.
   Google Scholar
• Bruce, D., Lambdin, B., Chang, O., Masao, F., Mbwambo, J., Mteza, I., et al. (2014). Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. International Journal of Drug Policy, 22–25.
   Google Scholar
• Coyle, S., Needle, R., & Normand, J. (1998). Outreach-based HIV prevention for injecting drug users: a review of published outcome data. Public Health Reports, 19–30.
   Google Scholar
• Deck, D., & Carlson, M. J. (2004). Access to publicly funded methadone maintenance treatment in two western states. The Journal of Behavioral Health Services & Research, 31(2), 164–177. https://doi.org/10.1007/BF02287379
   PubMed Web of Science ®Google Scholar
• Gari, S., Doig-Acuna, C., Smail, T., Malungo, J., Martin-Hilber, A., & Merten, S. (2013). Access to HIV/AIDS care: A systematic review of socio-cultural determinants in low and high income countries. BMC Health Services, 13, 198.
   PubMed Web of Science ®Google Scholar
• Guise, A., Kazatchkine, M., Rhodes, T., & Strathdee, S. (2014). Editorial commentary: Successful methadone delivery in east Africa and its global implications. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 59(5), 743–744. https://doi.org/10.1093/cid/ciu387
   PubMedGoogle Scholar
• Guise, A., Ndimbii, J., Igonya, E., Owiti, F., Strathdee, S., & Rhodes, T. (2019). Integrated and differentiated methadone and HIV care for people who use drugs: a qualitative study in Kenya with implications for implementation science. Health Policy and Planning.
   Google Scholar
• Guise, A., Tim, R., Ndimbii, J., & Ayon, S. (2015). The need for structural and community interventions to support HIV care and harm reduction for people who inject drugs in Kenya. Annals of Global Health, 81(1), 6. https://doi.org/10.1016/j.aogh.2015.02.527
   Google Scholar
• Harris, M., Rhodes, T., & Martin, A. (2013). Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting. Social Science and Medicine, 83(April 2013), 19–26.
   Web of Science ®Google Scholar
• Harm Reduction International. (2018). The global state of harm reduction. Harm Reduction International.
   Google Scholar
• Hunt, N. (n.d.). A review of the evidence-base for harm reduction approaches to drug use. Retrieved January 2, 2019, from Harm Reduction International. https://www.hri.global/files/2010/05/31/HIVTop50Documents11.pdf
   Google Scholar
• Isobell, D., Kamaloodien, K., & Savahl, S. (2015). A qualitative study of referring agents’ perceptions of access barriers to inpatient substance abuse treatment centres in the Western Cape. Harm Reduction Journal, 12, 36. https://doi.org/10.1186/s12954-015-0064-z
   Google Scholar
• Jennings, L., Mathai, M., Linnemayr, S., Trujillo, A., Mak’anyengo, M., Montgomery, B. E. E., & Kerrigan, D. L. (2017). Economic context and HIV vulnerability in adolescents and young adults living in urban slums in Kenya: A qualitative analysis based on scarcity theory. AIDS and Behavior, 21(9), 2784–2798. https://doi.org/10.1007/s10461-017-1676-y
   PubMed Web of Science ®Google Scholar
• Keeney, R., & Saucier, E. (2010). Lowering the threshold: Models of accessible methadone and buprenorphine treatment. Open Society Institute.
   Google Scholar
• Kelly, S. M., O’Grady, K. E., Schwartz, R. P., Peterson, J. A., Wilson, M. E., & Brown, B. S. (2010). The relationship of social support to treatment entry and engagement: The Community Assessment Inventory. Substance Abuse Jan; 31(1), 43–52.
   PubMed Web of Science ®Google Scholar
• Khampang, R., Assanangkornchai, S., & Teerawattananon, Y. (2015). Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand. Drug and Alcohol Review, 34(6), 645–653. https://doi.org/10.1111/dar.12268
   PubMed Web of Science ®Google Scholar
• Laswai, O., & Nsimba, S. (2017). Challenges in accessing medication assisted treatment among opiate users attending a methadone clinic in Dar Es Salaam, Tanzania: A qualitative assessment. Addiction Medicine and Therapy, 3(2), 44–50.
   Google Scholar
• Low, A. J., Mburu, G., Welton, N. J., May, M. T., Davies, C. F., French, C., Turner, K. M., Looker, K. J., Christensen, H., McLean, S., Rhodes, T., Platt, L., Hickman, M., Guise, A., & Vickerman, P. (2016). Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and meta-analysis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 63(8), 1094–1104. https://doi.org/10.1093/cid/ciw416
   PubMed Web of Science ®Google Scholar
• Luchenski, S., Maguire, N., Aldridge, R. W., Hayward, A., Story, A., Perri, P., Withers, J., Clint, S., Fitzpatrick, S., & Hewett, N. (2018). What works in inclusion health: Overview of effective interventions for marginalised and excluded populations. Lancet (London, England), 391(10117), 266–280. https://doi.org/10.1016/S0140-6736(17)31959-1
   PubMed Web of Science ®Google Scholar
• MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., Degenhardt, L., & Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. Bmj, 345(3), e5945. https://doi.org/10.1136/bmj.e5945
   PubMedGoogle Scholar
• Ministry of Health. (2017). The national protiocol for treatment of substance use disorders in Kenya. Ministry of health.
   Google Scholar
• Mofizul Islam, M., Topp, L., Conigrave, K. M., & Day, C. A. (2013). Defining a service for people who use drugs as ‘low-threshold’: What should be the criteria?The International Journal on Drug Policy, 24(3), 220–222. https://doi.org/10.1016/j.drugpo.2013.03.005
   PubMed Web of Science ®Google Scholar
• Mukandavire, C., Low, A., Mburu, G., Trickey, A., May, M. T., Davies, C. F., French, C. E., Looker, K. J., Rhodes, T., Platt, L., Guise, A., Hickman, M., & Vickerman, P. (2017). Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs. Aids (London, England), 31(8), 1181–1190. https://doi.org/10.1097/QAD.0000000000001458
   PubMed Web of Science ®Google Scholar
• Moser, A., & Korstjens, I. (2018). Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis. European Journal of General Practice, 24(1), 9–18.
   PubMed Web of Science ®Google Scholar
• NASCOP. (2013). Kenya national guidelines for standard operating procedure for medically assisted therapy for people who use drugs. Ministry of Health.
   Google Scholar
• Ndimbii, J., Guise, A., Ayon, S., Kalama, M., McLean, S., & Rhodes, T. (2015). Implementing Needle and Syringe Programs in Kenya: Changes, opportunities and challenges in HIV prevention. African Journal of Drug & Alcohol Studies, 14(2), 95–103.
   Google Scholar
• Needle, R., Kroeger, K., Belani, H., & Helge, J. (2006). Substance Abuse and HIV in Sub Saharan Africa:Introduction to the special issue. African Journal of Drugs and African Studies, 84–94.
   Google Scholar
• Nowell, L. S., Norris, J. M., White, D. E., & Moules, N. J. (2017). Thematic analysis: Striving to meet the trustworthiness criteria. International Journal of Qualitative Methods, 16(1), 160940691773384. https://doi.org/10.1177/1609406917733847
   Web of Science ®Google Scholar
• Philbin, M. M., & Fujie, Z. (2010). Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China. AIDS Care, 22(5), 623–629. https://doi.org/10.1080/09540120903311490
   PubMed Web of Science ®Google Scholar
• Rhodes, T. (2002). The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13(2), 85–94. https://doi.org/10.1016/S0955-3959(02)00007-5
   Google Scholar
• Rhodes, T., Closson, E., Paparini, S., Guise, A., & Strathdee, S. (2016). Towards ‘‘evidence-making intervention’’ approaches in the social science of implementation science: The making of methadone in East Africa. The International Journal on Drug Policy, 30, 17–26. https://doi.org/10.1016/j.drugpo.2016.01.002
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Guise, A., Ndimbii, J., Strathdee, S., Ngugi, E., & Platt, L. (2015). Is the promise of methadone Kenya’s solution to managing HIV and addiction? British Medical Journal, BMJ Open 2015, 5.
   Google Scholar
• Rhodes, T., Ndimbii, J., Guise, A., Cullen, L., & Ayon, S. (2015). Navigating the poverty of heroin addiction treatment and recovery opportunity in Kenya: Access work, self-care and rationed expectations. Global Public Health, 10(7), 867–1706. https://doi.org/10.1080/17441692.2015.1046385
   PubMed Web of Science ®Google Scholar
• Rhodes, T., & Sarang, A. (2012). Drug treatment and the conditionality of HIV treatment access: A qualitative study in a Russian city. Addiction, 107(10), 1827–1836. https://doi.org/10.1111/j.1360-0443.2012.03880.x
   PubMed Web of Science ®Google Scholar
• Sutton, J., & Austin, Z. (2015). Qualitative research: Data collection, analysis, and management. Canadian Journal of Hospital Pharmacy, 68(3), 226–231.
   PubMedGoogle Scholar
• Tran, B. X., Nguyen, L. H., Nguyen, L. P., Nguyen, C. T., Phan, H. T., & Latkin, C. A. (2016). Methadone maintenance treatment promotes referral and uptake of HIV testing and counselling services amongst drug users and their partners. PLOS One, 11(4), e0152804. https://doi.org/10.1371/journal.pone.0152804
   PubMed Web of Science ®Google Scholar
• Treloar, C., & Rance, J. (2014). How to build trustworthy hepatitis C services in an opioid treatmentclinic? A qualitative study of clients and health workers in a co-located setting. International Journal of Drug Policy, 25(5), 865–870.
   PubMed Web of Science ®Google Scholar
• Weeks, M., Convey, M., Dickson-Gomez, J., Li, J., Radda, K., & Martinez, M. (2009). Changing drug users’ risk environments: Peer health advocates as multi-level community change agents. American Journal of Community Psychology, 43(3-4), 330–344.
   PubMed Web of Science ®Google Scholar